Infectious complications among CD19 CAR-T cell therapy recipients: A single-center experience.

Bryan Walker Andrea J Zimmer Erica J StohsMatthew LunningElizabeth LydenAnum Abbas

Published in: Transplant infectious disease : an official journal of the Transplantation Society (2023)

Infections were common after CD19 CAR-T cell therapy and occurred beyond the first year. Further multicenter studies are needed to define infectious risks and optimize antimicrobial prophylaxis recommendations in recipients of CD19 CAR-T cell therapy.

Keyphrases

cell therapy
stem cells
mesenchymal stem cells
nk cells
staphylococcus aureus
clinical trial
cross sectional
human health